ICU Medical, Inc. (ICUI)
154.15
+1.68
(+1.10%)
USD |
NASDAQ |
Feb 25, 15:55
ICU Medical Research and Development Expense (Quarterly) : 21.09M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merit Medical Systems, Inc. | 23.97M |
| InfuSystem Holdings, Inc. | -- |
| Tandem Diabetes Care, Inc. | 46.07M |
| iRhythm Holdings, Inc. | 21.05M |
| Plus Therapeutics, Inc. | 2.436M |